Tesa10+IP5 (Tesamorelin & Ipamorelin)
The Tesa10 + IP5 complex is a sophisticated research blend combining 10mg of Tesamorelin and 5mg of Ipamorelin, totaling 15mg of active lyophilized peptide. This formulation is specifically designed for laboratory research into the synergistic “Push-Pull” mechanism of growth hormone regulation. While Tesamorelin acts as a potent GHRH (Growth Hormone-Releasing Hormone) analog that stimulates the pituitary, Ipamorelin functions as a highly selective GHRP (Growth Hormone-Releasing Peptide) and ghrelin receptor agonist. Together, they provide a multi-pathway model for studying maximal endogenous growth hormone pulsatility and its effects on metabolic signaling.
Produced in an ISO 9001:2015 certified and GMP-grade facility, our Tesa10 + IP5 blend utilizes high-precision co-lyophilization technology. This ensures that both peptides are uniformly distributed within a single vial, maintaining a chemical purity of ≥99%. This meticulous standard is essential for researchers requiring exact molar ratios to study complex endocrine feedback loops and adipose tissue lipolysis without interference from synthesis by-products.
Research Applications & Mechanisms
Synergistic GH Pulsatility
Investigating how the simultaneous stimulation of GHRH and GHRP receptors influences the amplitude and frequency of growth hormone secretion in cellular models.
Metabolic & Lipolytic Research
Studying the combined effect of Tesamorelin and Ipamorelin on visceral adipose tissue reduction and lipid oxidation pathways.
Somatotropic Axis Homeostasis
Researching the interplay between exogenous peptide administration and the natural feedback mechanisms involving Somatostatin and IGF-1.
Selective Signaling Analysis
Utilizing Ipamorelin’s high selectivity to study GH release without the significant elevations in cortisol or prolactin often associated with less refined secretagogues.
Technical Specifications
| Parameter | Laboratory Standard |
| Components | Tesamorelin (10mg) / Ipamorelin (5mg) |
| Total Concentration | 15mg per vial |
| Production Quality | GMP-Level Compliance |
| Purity (HPLC) | ≥99% (Pharmaceutical Grade) |
| Physical Appearance | Fine, Smooth & Flat Lyophilized Cake |
| Solubility | Highly Soluble in Water / Bacteriostatic Water |
| Batch Control | MS & HPLC Analysis Verified |
Key Features & Quality Assurance
Precision Co-Lyophilization
Our proprietary vacuum-sealing and freeze-drying process ensures the Tesa10 + IP5 powder surface is perfectly smooth, flat, and delicate. This ensures that the two distinct peptide chains remain stable and do not interact prematurely before reconstitution.
Quantitative Accuracy
Every vial is rigorously tested to ensure the exact 10:5 ratio is maintained, providing the batch-to-batch consistency required for reproducible metabolic research.
Reconstitution & Storage
Reconstitution Guide
-
Preparation: Allow the vial to reach room temperature. Centrifuge for 30-60 seconds to ensure the Tesa + IP cake is at the base.
-
Solvent: Reconstitute with Sterile Water or Bacteriostatic Water.
-
Technique: Introduce the diluent gently. DO NOT SHAKE; swirl the vial softly until the solution is clear and transparent.
Storage Protocols
-
Long-term: Store at -20°C (Stable for up to 24 months).
-
Short-term: Stable at 2–8°C for up to 3 months.
-
Post-Reconstitution: Store at 2–8°C and utilize within 7-10 days for maximum potency.
Shipping & Documentation
-
Global Logistics: Shipped in discreet, temperature-controlled packaging to protect the sensitive Tesa + IP peptide sequences.
-
Verified Quality: A batch-specific COA and HPLC/MS reports are available for every order.
-
Reshipment Policy: We provide a guaranteed reshipment policy for any lost or customs-intercepted orders (terms apply).
⚠️ Research Disclaimer
Product-Specific Safety Notice: This Tesa10 + IP5 blend is strictly for laboratory research and analytical purposes. It is NOT intended for human or veterinary administration. Handling must be performed by qualified professionals.
Scientific Resources & References
-
NCBI/PubChem: Tesamorelin (CID 16137828) & Ipamorelin (CID 9831659)
-
ScienceDirect: Synergistic Effects of GHRH and GHRP in Growth Hormone Stimulation Research
🔍 Deep Dive Research
-
[Technical Guide]: How to Reconstitute and Store Lyophilized Peptides for Maximum Potency
-
[Synergy Study]: The Push-Pull Mechanism: Understanding GHRH and GHRP Co-administration










ubaskank –
Good enough.